Welcome to our 'Medicines regulatory news' section.
This section provides the latest information about the regulation of medicines, including information that was previously published in 'MAIL', our updating journal for medicines which ceased publication at the end of 2007.
Free email alerting service
If you would like to receive an email notification when new content is added to this section, please subscribe to our free email alerting service (see under 'Regulatory information - medicines' on the registration form):hsb
›
MHRA email alerting service
We hope you find this section useful. If you have any suggestions on how it could be improved, please email webusability@mhra.gsi.gov.uk
Latest medicines regulatory news
-
09 Feb 2012 | Monthly performance on vetting of advertising - January 2012
Details of the monthly percentage of advertising pieces submitted for vetting where the MHRA provided a response to the company within the target response time of five working days. Updated for January 2012.
-
08 Feb 2012 | Medicines for children: Publication of assessment reports for European Article 45 paediatric work-sharing procedures - 8 February 2012
On 30 January 2012, CMDh published paediatric assessment reports following completion of three Article 45 work-sharing procedure.
-
08 Feb 2012 | Patient information leaflet (PIL) of the month: Imodium Instants
The patient information leaflet for Immodium Instants has been added to the patient information leaflet (PIL) of the month section of the website.
-
31 Jan 2012 | Pre-consultation questionnaire for the 'Falsified Medicines Directive' (Directive 2011/62/EU) - closes 3 February 2012
The MHRA is seeking information from industry professionals to inform an initial economic Impact Assessment following publication by the European Commission of Directive 2011/62/EU concerning falsified medicines.
-
27 Jan 2012 | Summary Report for Importation of Unlicensed Medicines
This report reviews the Import Notification System (INS) to the end of June 2011.
-
27 Jan 2012 | Complaints about advertising of medicines - 27 January 2012
The MHRA have published the results of four investigations into the advertising of medicines.
-
20 Jan 2012 | MHRA technical validation of marketing authorisation applications (MAAs) for medicines - Updated 20 January 2012
From 3 January 2012, the MHRA will be technically validating all new eCTD (common technical document) submissions.
-
06 Jan 2012 | Complaints about advertising of medicines – 6 January 2012
We have published the result of an investigation into the advertising of medicines.
-
06 Jan 2012 | Monthly performance on vetting of advertising - December 2011
Details of the monthly percentage of advertising pieces submitted for vetting where the MHRA provided a response to the company within the target response time of five working days. Updated for December 2011
-
21 Dec 2011 | Consultation MLX 363 - Fees legislation for 2012
This consultation seeks views on proposals to change the levels of fees charged by the MHRA for the regulation of medicines, including herbal and homoeopathic medicines, and blood establishments and blood banks. The deadline for responses is 31 January 2012.
